Posters & Publications

Date	Title	View
Sep 23, 2023	ESPE 2023 Oral Presentation – Deconvolution Analysis: Oral LUM-201 Enhances Growth in PGHD by Enhancing Endogenous GH Secretion & Increasing IGF-1	ESPE 2023 Oral Presentation – Deconvolution Analysis: Oral LUM-201 Enhances Growth in PGHD by Enhancing Endogenous GH Secretion & Increasing IGF-1 1.2 MB
Jun 17, 2023	ENDO 2023 Oral Presentation - Growth Response of Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Combined Analysis Interim Analysis Data	ENDO 2023 Oral Presentation - Growth Response of Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Combined Analysis Interim Analysis Data 1 MB
Jun 17, 2023	ENDO 2023 Oral Presentation - LUM-201 Dose Response Measured by Acute GH, IGF-1, and Annualized Height Velocity (AHV) from Interim Analysis of OraGrowtH212 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)	ENDO 2023 Oral Presentation - LUM-201 Dose Response Measured by Acute GH, IGF-1, and Annualized Height Velocity (AHV) from Interim Analysis of OraGrowtH212 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD) 1.7 MB
May 07, 2023	PES 2023 Poster - Observed IGF-1 Serum Concentration Increase Within Normal Range After Prolonged Daily Oral LUM-201 Administration in Idiopathic Pediatric Growth Hormone Deficiency from the OraGrowtH212 Trial: Interim Analysis Data	PES 2023 Poster - Observed IGF-1 Serum Concentration Increase Within Normal Range After Prolonged Daily Oral LUM-201 Administration in Idiopathic Pediatric Growth Hormone Deficiency from the OraGrowtH212 Trial: Interim Analysis Data 1.9 MB
May 07, 2023	PES 2023 Oral Presentation - Growth Response to LUM-201 in the OraGrowtH210 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Interim Analysis Data (41 Subjects)	PES 2023 Oral Presentation - Growth Response to LUM-201 in the OraGrowtH210 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Interim Analysis Data (41 Subjects) 1.1 MB
Mar 05, 2023	IMPE 2023 Poster – Baseline Demographics of the OraGrowtH210 Trial Studying LUM-201 in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD) Interim Analysis Data	IMPE 2023 Poster – Baseline Demographics of the OraGrowtH210 Trial Studying LUM-201 in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD) Interim Analysis Data 1.4 MB
Mar 05, 2023	IMPE 2023 Oral Presentation – Dose-dependent Increase in GH AUC0-12h with LUM-201 in Idiopathic Pediatric GH Deficiency (iPGHD) from the Interim Analysis Data of the OraGrowtH212 Trial	IMPE 2023 Oral Presentation – Dose-dependent Increase in GH AUC0-12h with LUM-201 in Idiopathic Pediatric GH Deficiency (iPGHD) from the Interim Analysis Data of the OraGrowtH212 Trial 1.1 MB
Mar 30, 2022	A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial	A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than …
Mar 20, 2021	LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency	LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric…
Mar 04, 2021	Development of a Predictive Enrichment Marker for Oral GH Secretagogue LUM-201 in Children with Growth Hormone Deficiency	Development of a Predictive Enrichment Marker for Oral GH Secretagogue LUM-201 in Children with Growth Hormone Deficiency 220 KB
Mar 04, 2021	Corroboration of Height Velocity Prediction Markers for rhGH with an Oral GH Secretagogue Treatment in Children with GHD	Corroboration of Height Velocity Prediction Markers for rhGH with an Oral GH Secretagogue Treatment in Children with GHD 611.9 KB

Posters & Publications

Posters & Publications

Stay Connected